| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |